← Back to Bills
HR 8869118th CongressFailed / ExpiredHouse

IVF Protection Act

Policy Area: Health
View on Congress.gov
Origin Chamber
House
Last Updated
Nov 15, 2024
Latest Action Date
Jun 27, 2024

Latest Action

Referred to the House Committee on Energy and Commerce.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The IVF Protection Act (H.R. 8869) was a bill introduced in the 118th Congress aimed at addressing issues related to in vitro fertilization (IVF). The bill was referred to the House Committee on Energy and Commerce but did not advance further and ultimately failed or expired. Specific details about the bill's provisions, objectives, or regulatory changes are not available in the provided data, as the official summary and full text are missing.

Bottom Line

H.R. 8869, the IVF Protection Act, was introduced but did not progress beyond committee referral and expired without becoming law. Limited information is available about its content or intended impact.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill was introduced in the House during the 118th Congress and referred to the House Committee on Energy and Commerce on June 27, 2024.
  • The bill relates to the health policy area, specifically focusing on in vitro fertilization (IVF).
  • The bill's status is marked as failed or expired, indicating it did not pass or advance in the legislative process.
Who Benefits?

['Potential beneficiaries could have included individuals or couples seeking IVF treatments, healthcare providers specializing in fertility services, and related medical industries, although specific beneficiaries cannot be identified due to lack of bill text.']

Potential Concerns

['Without the full text or summary, it is unclear what implementation challenges, costs, or oversight mechanisms the bill proposed.', 'The absence of detailed provisions limits assessment of authority delegation or regulatory impact.', 'Potential tradeoffs related to healthcare access, insurance coverage, or medical standards cannot be evaluated.']

Political Context

The bill was introduced in the House and referred to the Energy and Commerce Committee, a common committee for health-related legislation. Its failure to advance suggests it did not gain sufficient legislative support or priority during the 118th Congress. No further legislative actions or debates are recorded in the provided data.

Hidden Impact Review

Hidden impact flags detected: 1

GovScope reviewed 1 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

1 Detected
Detected Flags
Indirect Effects

['If enacted, the bill could have influenced IVF treatment regulations, insurance coverage policies, or patient protections, potentially affecting healthcare providers and patients indirectly.', 'The referral to the Energy and Commerce Committee suggests possible intersections with broader health policy and medical industry regulations.']

GovScope Watchdog Notes

The absence of an official summary and full bill text significantly limits transparency and public oversight. Tracking the bill's referral and failure to advance highlights the importance of accessible legislative documentation for informed public engagement and accountability.

Passage Likelihood: LowConfidence: 40%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready